IP Verse

Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia

EP2925324

RICHTER GEDEON NYRT.
Application Number
EP13805597A
Filing Date
Nov 28, 2013
Status
Granted And Under Opposition
Nov 27, 2020
Grant Date
Dec 30, 2020
External Links
Slate, Register

Biblio Summary

The patent EP2925324B1 was granted on Dec 30, 2020 by Richter Gedeon Nyrt. The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KRKA, D.D., NOVO MESTOSep 30, 2021ADMISSIBLE
WITTKOPP, ALEXANDERSep 29, 2021ADMISSIBLE

More Opposed Patents of Richter Gedeon Nyrt.

The table below shows the patents of Richter Gedeon Nyrt. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3877395Industrial Process For The Preparation Of High Purity EstetrolDec 7, 20221
EP2828396Method For The Production Of PolypeptidesApr 24, 20191
EP3212667Pharmaceutical Anti-Tnf-Alpha Antibody FormulationSep 19, 20183

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents